“…It is noteworthy that, at stage 32 (present results), the NLT is negative for the markers considered here, although it is positive for ScLhx5 at previous stages ( Santos-Durán et al, 2018 ). Similarly, the mammalian ventromedial nucleus seems to be positive for Lhx5 and abuts Dlx -expressing territories at early stages ( Sheng et al, 1997 ; Abellán et al, 2010 ), but it is negative at later stages ( Szabó et al, 2009 ; Heide et al, 2015 ; Miquelajáuregui et al, 2015 ). The catshark NLT presents several types of peptidergic cells (somatostatin, Sobrido-Cameán et al, 2020 ; met-enkephalin and leu-enkephalin, Vallarino et al, 1994 ; melanin-concentrating hormone, Vallarino et al, 1989a ; atrial natriuretic factor, Vallarino et al, 1990b ; delta sleep-inducing peptide, Vallarino et al, 1992 ; beta-endorphin, Vallarino et al, 1989b ; galanin, Vallarino et al, 1991 ; neuropeptide Y, Vallarino et al, 1988 ; corticotropin-releasing factor, Vallarino et al, 1989c ; adrenocorticotropic hormone, Vallarino and Ottonello, 1987 , Vallarino et al, 1989b ), and is thought to be associated with the hypophysis, as reported in actinopterygian fishes (reviewed in Butler and Hodos, 2005 ).…”